Advanced Enzyme Technologies
- Advice
- Hold
Advanced Enzyme Technologies Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Advanced Enzyme Technologies
Start SIPAdvanced Enzyme Technologies Investment Rating
-
Master Rating:
-
Advanced Enzyme Techs. has an operating revenue of Rs. 540.64 Cr. on a trailing 12-month basis. An annual revenue growth of 6% is not great, Pre-tax margin of 26% is great, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 7% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 71 which is a FAIR score but needs to improve its earnings, a RS Rating of 43 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 120 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 83 | 80 | 77 | 72 | 71 |
Operating Expenses Qtr Cr | 59 | 58 | 58 | 61 | 55 |
Operating Profit Qtr Cr | 23 | 21 | 19 | 11 | 15 |
Depreciation Qtr Cr | 3 | 3 | 3 | 2 | 3 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 6 | 6 | 5 | 2 | 4 |
Net Profit Qtr Cr | 17 | 17 | 14 | 8 | 14 |
Advanced Enzyme Technologies Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹275.85
- 50 Day
- ₹270.16
- 100 Day
- ₹270.24
- 200 Day
- ₹276.48
- 20 Day
- ₹277.96
- 50 Day
- ₹262.24
- 100 Day
- ₹267.99
- 200 Day
- ₹274.54
Advanced Enzyme Technologies Resistance and Support
Resistance | |
---|---|
First Resistance | ₹291.39 |
Second Resistance | ₹297.17 |
Third Resistance | ₹305.34 |
RSI | 58.73 |
MFI | 50.76 |
MACD Single Line | 4.24 |
MACD | 3.93 |
Support | |
---|---|
First Resistance | ₹277.44 |
Second Resistance | ₹269.27 |
Third Resistance | ₹263.49 |
Advanced Enzyme Technologies Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 163,834 | 7,770,647 | 47.43 |
Week | 106,121 | 5,837,738 | 55.01 |
1 Month | 104,514 | 5,321,855 | 50.92 |
6 Month | 91,893 | 4,456,796 | 48.5 |
Advanced Enzyme Technologies Result Highlights
Advanced Enzyme Technologies Synopsis
NSE-Chemicals-Specialty
Advanced Enzyme Tech is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 311.53 Cr. and Equity Capital is Rs. 22.37 Cr. for the Year ended 31/03/2023. Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018.Market Cap | 3,157 |
Sales | 312 |
Shares in Float | 5.59 |
No of funds | 78 |
Yield | 0.35 |
Book Value | 6.01 |
U/D Vol ratio | 0.8 |
LTDebt / Equity | |
Alpha | -0.07 |
Beta | 0.98 |
Advanced Enzyme Technologies
Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
---|---|---|---|---|
Promoters | 49.87% | 49.87% | 49.87% | 52.7% |
Mutual Funds | 5.29% | 5.25% | 5.36% | 6.05% |
Foreign Portfolio Investors | 21.86% | 21.74% | 21.68% | 18.72% |
Individual Investors | 13.28% | 13.42% | 13.36% | 15.14% |
Others | 9.7% | 9.72% | 9.73% | 7.39% |
Advanced Enzyme Technologies Management
Name | Designation |
---|---|
Mr. Vasant Rathi | Non Executive Chairman |
Mr. Mukund M Kabra | Whole Time Director |
Ms. Rasika Rathi | Non Executive Director |
Dr. Sunny Sharma | Non Executive Director |
Mr. Rajesh Sharma | Independent Director |
Mr. Kedar Jagdish Desai | Independent Director |
Mr. Pramod Kasat | Independent Director |
Mr. Nitin Desmukh | Independent Director |
Mr. Vinodkumar Jajoo | Independent Director |
Ms. Rajshree Patel | Independent Director |
Advanced Enzyme Technologies Forecast
Price Estimates
Advanced Enzyme Technologies Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-05-13 | Audited Results & Dividend | |
2023-02-11 | Quarterly Results | |
2022-11-11 | Quarterly Results | |
2022-08-06 | Quarterly Results | |
2022-05-20 | Audited Results & Final Dividend |
Date | Purpose | Remarks |
---|---|---|
2023-05-20 | INTERIM | Rs.4.00 per share(200%)Interim Dividend |
2022-08-12 | FINAL | Rs.1.00 per share(50%)Final Dividend |
2021-09-01 | FINAL | Rs.0.90 per share(45%)Final Dividend |
Advanced Enzyme Technologies FAQs
What is Share Price of Advanced Enzyme Technologies ?
Advanced Enzyme Technologies share price is ₹282 As on 03 June, 2023 | 22:48
What is the Market Cap of Advanced Enzyme Technologies ?
The Market Cap of Advanced Enzyme Technologies is ₹3156.8 Cr As on 03 June, 2023 | 22:48
What is the P/E ratio of Advanced Enzyme Technologies ?
The P/E ratio of Advanced Enzyme Technologies is 29.9 As on 03 June, 2023 | 22:48
What is the PB ratio of Advanced Enzyme Technologies ?
The PB ratio of Advanced Enzyme Technologies is 2.5 As on 03 June, 2023 | 22:48